Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium

Luca Freschi, Julie Jeukens, Irena Kukavica-Ibrulj, Brian Boyle, Marie-Josée Dupont, Jérôme Laroche, Stéphane Larose, Halim Maaroufi, Joanne L. Fothergill, Matthew Moores, Geoffrey L. Winsor, Shawn D. Aaron, Jean Barbeau, Scott C. Bell, Jane L. Burns, Miguel Camara, André Cantin, Steve J. Charette, Ken Dewar, Éric DézielKeith Grimwood, Robert E. W. Hancock, Joe J. Harrison, Stephan Heeb, Lars Jelsbak, Baofeng Jia, Dervla T. Kenna, Timothy J. Kidd, Jens Klockgether, Joseph S. Lam, Iain L. Lamont, Shawn Lewenza, Nick Loman, François Malouin, Jim Manos, Andrew G. McArthur, Josie McKeown, Julie Milot, Hardeep Naghra, Dao Nguyen, Sheldon K. Pereira, Gabriel G. Perron, Jean-Paul Pirnay, Paul B. Rainey, Simon Rousseau, Pedro M. Santos, Anne Stephenson, Véronique Taylor, Jane F. Turton, Nicholas Waglechner, Paul Williams, Sandra W. Thrane, Gerard D. Wright, Fiona S. L. Brinkman, Nicholas P. Tucker, Burkhard Tümmler, Craig Winstanley, Roger C. Levesque

Research output: Contribution to journalArticlepeer-review

94 Citations (Scopus)
68 Downloads (Pure)


The International Pseudomonas aeruginosa Consortium is sequencing over 1000 genomes and building an analysis pipeline for the study of Pseudomonas genome evolution, antibiotic resistance and virulence genes. Metadata, including genomic and phenotypic data for each isolate of the collection, are available through the International Pseudomonas Consortium Database ( Here, we present our strategy and the results that emerged from the analysis of the first 389 genomes. With as yet unmatched resolution, our results confirm that P. aeruginosa strains can be divided into three major groups that are further divided into subgroups, some not previously reported in the literature. We also provide the first snapshot of P. aeruginosa strain diversity with respect to antibiotic resistance. Our approach will allow us to draw potential links between environmental strains and those implicated in human and animal infections, understand how patients become infected and how the infection evolves over time as well as identify prognostic markers for better evidence-based decisions on patient care.
Original languageEnglish
Article number1036
Number of pages8
JournalFrontiers in Microbiology
Publication statusPublished - 29 Sep 2015


  • infectious diseases
  • pseudomonas genomes
  • P. aeruginosa
  • genome comparison


Dive into the research topics of 'Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium'. Together they form a unique fingerprint.

Cite this